Lv11
58 积分 2026-04-17 加入
Covalent inhibitors of human cytochrome P450 3A4: research advances and future perspectives
7小时前
待确认
Synthetic Approaches to the New Drugs Approved During 2024
1个月前
已完结
Recent advances in the design of small molecular drugs with acrylamides covalent warheads
2个月前
已完结
Discovery of a High-Potency Balanced GLP-1/GIP Dual Agonist by Molecular Dynamics Evolution
2个月前
已完结
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
3个月前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial
3个月前
已完结
皖公网安备34019202002308
